Role of Embolization in the Treatment of Renal Masses
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/02/20
-
Indian UGC (journal)
-
Citations35
-
David Li Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, New York, New York
-
Bradley Pua Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, New York, New York
-
David Madoff Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, New York, New York
Cite
Li, David, et al. “Role of Embolization in the Treatment of Renal Masses”. Seminars in Interventional Radiology, vol. 31, no. 01, 2014, pp. 070-81, https://doi.org/10.1055/s-0033-1363845.
Li, D., Pua, B., & Madoff, D. (2014). Role of Embolization in the Treatment of Renal Masses. Seminars in Interventional Radiology, 31(01), 070-081. https://doi.org/10.1055/s-0033-1363845
Li D, Pua B, Madoff D. Role of Embolization in the Treatment of Renal Masses. Seminars in Interventional Radiology. 2014;31(01):070-81.
Journal Categories
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
- Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System
- Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee
- Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Management conundrum in a case of renal cell cancer (RCC) on dual antiplatelet therapy (DAPT) for recently placed coronary drug-eluting stent (DES) | BMJ Case Reports |
| 2024 | |
| Wunderlich Syndrome: Comprehensive Review of Diagnosis and Management | RadioGraphics |
| 3 | 2023 |
A systematic review and meta-analysis on the efficacy of preoperative renal artery embolization prior to radical nephrectomy for renal cell carcinoma: Is it necessary? | Archivio Italiano di Urologia e Andrologia |
| 2023 | |
Case Series of Angioembolization of Genitourinary System Between 2004 and 2016 | Multidisciplinary Cardiovascular Annals | 2023 | ||
| Performance of cone-beam computed tomography (CBCT) renal arteriography for renal tumor embolization | European Journal of Radiology |
| 1 | 2022 |
Citations Analysis
The category
Medicine: Medicine (General) 18
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art and was published in 2014. The most recent citation comes from a 2024 study titled Management conundrum in a case of renal cell cancer (RCC) on dual antiplatelet therapy (DAPT) for recently placed coronary drug-eluting stent (DES). This article reached its peak citation in 2021, with 6 citations. It has been cited in 31 different journals, 19% of which are open access. Among related journals, the Clinical Imaging cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.